chr8-85206201-C-A

Variant summary

Our verdict is Likely benign. Variant got -2 ACMG points: 2P and 4B. PP3_ModerateBS2

The NM_001951.4(E2F5):​c.531C>A​(p.Asp177Glu) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00000821 in 1,460,948 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a pathogenic outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★).

Frequency

Genomes: not found (cov: 32)
Exomes 𝑓: 0.0000082 ( 0 hom. )

Consequence

E2F5
NM_001951.4 missense

Scores

7
7
5

Clinical Significance

Uncertain significance criteria provided, single submitter U:1

Conservation

PhyloP100: 0.316
Variant links:
Genes affected
E2F5 (HGNC:3119): (E2F transcription factor 5) The protein encoded by this gene is a member of the E2F family of transcription factors. The E2F family plays a crucial role in the control of cell cycle and action of tumor suppressor proteins and is also a target of the transforming proteins of small DNA tumor viruses. The E2F proteins contain several evolutionarily conserved domains that are present in most members of the family. These domains include a DNA binding domain, a dimerization domain which determines interaction with the differentiation regulated transcription factor proteins (DP), a transactivation domain enriched in acidic amino acids, and a tumor suppressor protein association domain which is embedded within the transactivation domain. This protein is differentially phosphorylated and is expressed in a wide variety of human tissues. It has higher identity to E2F4 than to other family members. Both this protein and E2F4 interact with tumor suppressor proteins p130 and p107, but not with pRB. Alternative splicing results in multiple variants encoding different isoforms. [provided by RefSeq, Jul 2008]

Genome browser will be placed here

ACMG classification

Classification made for transcript

Verdict is Likely_benign. Variant got -2 ACMG points.

PP3
MetaRNN computational evidence supports a deleterious effect, 0.873
BS2
High AC in GnomAdExome4 at 12 AD gene.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect #exon/exons MANE Protein UniProt
E2F5NM_001951.4 linkuse as main transcriptc.531C>A p.Asp177Glu missense_variant 4/8 ENST00000416274.7 NP_001942.2
E2F5NM_001083588.2 linkuse as main transcriptc.531C>A p.Asp177Glu missense_variant 4/8 NP_001077057.1
E2F5NM_001083589.2 linkuse as main transcriptc.48C>A p.Asp16Glu missense_variant 4/8 NP_001077058.1

Ensembl

Gene Transcript HGVSc HGVSp Effect #exon/exons TSL MANE Protein Appris UniProt
E2F5ENST00000416274.7 linkuse as main transcriptc.531C>A p.Asp177Glu missense_variant 4/81 NM_001951.4 ENSP00000398124 P4Q15329-1

Frequencies

GnomAD3 genomes
Cov.:
32
GnomAD3 exomes
AF:
0.00000804
AC:
2
AN:
248694
Hom.:
0
AF XY:
0.00
AC XY:
0
AN XY:
134980
show subpopulations
Gnomad AFR exome
AF:
0.0000646
Gnomad AMR exome
AF:
0.00
Gnomad ASJ exome
AF:
0.00
Gnomad EAS exome
AF:
0.00
Gnomad SAS exome
AF:
0.00
Gnomad FIN exome
AF:
0.00
Gnomad NFE exome
AF:
0.00000887
Gnomad OTH exome
AF:
0.00
GnomAD4 exome
AF:
0.00000821
AC:
12
AN:
1460948
Hom.:
0
Cov.:
30
AF XY:
0.00000688
AC XY:
5
AN XY:
726796
show subpopulations
Gnomad4 AFR exome
AF:
0.0000299
Gnomad4 AMR exome
AF:
0.00
Gnomad4 ASJ exome
AF:
0.00
Gnomad4 EAS exome
AF:
0.00
Gnomad4 SAS exome
AF:
0.00
Gnomad4 FIN exome
AF:
0.00
Gnomad4 NFE exome
AF:
0.00000990
Gnomad4 OTH exome
AF:
0.00
GnomAD4 genome
Cov.:
32
Alfa
AF:
0.0000312
Hom.:
0
Bravo
AF:
0.00000378
ExAC
AF:
0.0000165
AC:
2

ClinVar

Significance: Uncertain significance
Submissions summary: Uncertain:1
Revision: criteria provided, single submitter
LINK: link

Submissions by phenotype

not specified Uncertain:1
Uncertain significance, criteria provided, single submitterclinical testingAmbry GeneticsFeb 17, 2022The c.531C>A (p.D177E) alteration is located in exon 4 (coding exon 4) of the E2F5 gene. This alteration results from a C to A substitution at nucleotide position 531, causing the aspartic acid (D) at amino acid position 177 to be replaced by a glutamic acid (E). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Pathogenic
0.91
BayesDel_addAF
Pathogenic
0.39
D
BayesDel_noAF
Pathogenic
0.51
CADD
Uncertain
24
DANN
Uncertain
1.0
DEOGEN2
Benign
0.28
.;T;.;T
Eigen
Uncertain
0.25
Eigen_PC
Uncertain
0.24
FATHMM_MKL
Uncertain
0.96
D
LIST_S2
Pathogenic
0.98
D;D;D;D
M_CAP
Benign
0.056
D
MetaRNN
Pathogenic
0.87
D;D;D;D
MetaSVM
Benign
-0.33
T
MutationAssessor
Pathogenic
3.0
M;M;.;.
MutationTaster
Benign
1.0
D;D;D;D;N
PrimateAI
Uncertain
0.72
T
PROVEAN
Uncertain
-3.5
D;D;D;D
REVEL
Pathogenic
0.84
Sift
Benign
0.038
D;D;D;D
Sift4G
Uncertain
0.047
D;D;D;D
Polyphen
0.99
D;D;.;.
Vest4
0.94
MutPred
0.76
Gain of helix (P = 0.1736);Gain of helix (P = 0.1736);.;.;
MVP
0.98
MPC
0.44
ClinPred
0.91
D
GERP RS
2.3
Varity_R
0.72
gMVP
0.61

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.13
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

LitVar

Below is the list of publications found by LitVar. It may be empty.

Other links and lift over

dbSNP: rs749670424; hg19: chr8-86118436; API